# Evaluation the Effectiveness of the Risk Minimisation Activities in the Treatment of Stroke Prevention in Atrial Fibrillation

> **NCT02433366** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 1213 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02433366
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 1213 (ACTUAL)
- **Last updated:** 2016-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02433366

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02433366, "Evaluation the Effectiveness of the Risk Minimisation Activities in the Treatment of Stroke Prevention in Atrial Fibrillation". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02433366. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*